STOFF 2018 | Society for Translational Oncology

2018 STOFF

Bruce A. Chabner, MD
Massachusetts General Hospital Cancer Center,
Boston, Massachusetts, USA

Susan Hilsenbeck, PhD
Baylor College of Medicine,
Houston, Texas, USA

Stacey Berg, MD
Texas Children’s Cancer Center, Texas Children’s Hospital,
Baylor College of Medicine, Houston, TX, USA

Bernardo H.L. Goulart, MD, MS
University of Washington
Seattle Cancer Care Alliance, Seattle, Washington, USA

Keith Flaherty, MD
Massachusetts General Hospital Cancer Center,
Boston, Massachusetts, USA

Ross Levine, MD
Memorial Sloan Kettering Cancer Center,
New York, New York, USA

Tatiana Prowell, MD
City of Hope Comprehensive Cancer Center,
Duarte, California, USA

Mark W. Duncan, PhD
University of Colorado,
Denver, Colorado, USA

Kiran Patel, MD
Janssen Research & Development, LLC,
Raritan, New Jersey, USA

Michael Maitland, MD
Schar Cancer Institute, Inova Health System,
Annandale, Virginia, USA

Kerry Reynolds, MD
Massachusetts General Hospital Cancer Center,
Boston, Massachusetts, USA

Carlos Ramos, MD
Cleveland Clinic,
Cleveland, Ohio, USA

Ryan Corcoran, MD, PhD
Massachusetts General Hospital Cancer Center,
Boston, Massachusetts, USA

Neil Hayes, MD
University of Tennessee Health Science Center,
Germantown, Tennessee, USA

This activity is sponsored by the Society for Translational Oncology. STO gratefully acknowledges the support of the 2018 Fellows’ Forum from: